TrialJournal of the American Heart Association2024

Novel Relaxin Receptor RXFP1 Agonist AZD3427 in the Treatment of Heart Failure: A Phase 1a/b, First-in-Human, Randomized, Single-Blind, Placebo-Controlled Study.

Kathleen Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.